Michael Ackermann's most recent trade in Tarsus Pharmaceuticals Inc was a trade of 12,000 Restricted Stock Units done . Disclosure was reported to the exchange on June 16, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tarsus Pharma Inc | Michael Ackermann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 12,000 | 12,000 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | Michael Ackermann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 7,000 | 7,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharma Inc | Michael Ackermann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 4,257 | 0 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | Michael Ackermann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 4,257 | 1,208,273 | - | - | Common Stock | |
| Tarsus Pharma Inc | Michael Ackermann | Director | Purchase of securities on an exchange or from another person at price $ 13.50 per share. | 05 May 2022 | 100,000 | 100,000 | - | 13.5 | 1,350,000 | Common Stock |
| Tarsus Pharma Inc | Michael Ackermann | Director | Sale of securities on an exchange or to another person at price $ 27.76 per share. | 01 Nov 2021 | 4,964 | 1,210,718 | - | 27.8 | 137,801 | Common Stock |
| Tarsus Pharma Inc | Michael Ackermann | Director | Sale of securities on an exchange or to another person at price $ 28.18 per share. | 01 Nov 2021 | 869 | 1,209,849 | - | 28.2 | 24,488 | Common Stock |
| Tarsus Pharma Inc | Michael Ackermann | Director | Sale of securities on an exchange or to another person at price $ 26.45 per share. | 12 Oct 2021 | 4,517 | 1,215,682 | - | 26.5 | 119,475 | Common Stock |
| Tarsus Pharma Inc | Michael Ackermann | Director | Sale of securities on an exchange or to another person at price $ 25.56 per share. | 12 Oct 2021 | 1,116 | 1,220,199 | - | 25.6 | 28,525 | Common Stock |
| Tarsus Pharma Inc | Michael Ackermann | Director | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 08 Oct 2021 | 200 | 1,221,315 | - | 25.0 | 5,006 | Common Stock |